go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Louisiana rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $794,328 · 10th–90th $562,341$1,737,8010%20%40%10th90th$794,328Professionalmedian $562,341 · 10th–90th $562,341$676,0830%50%90th$562,341$500.0K$1.0M$2.0M$5.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$794,328.23
Typical High
$1,737,800.83
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$575,439.94
United
Setting
Professional
Modifier
Global
Typical Low
$407,380.28
Median
$512,861.38
Typical High
$575,439.94